Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Insmed Inc. | 42 | 0 | 9 | 0 | €68.00 | €75.67 | 11.279% |
Cytokinetics Inc. | 34 | 1 | 0 | 0 | €55.00 | €83.92 | 52.575% |
Intra-Cellular Therapies Inc. | 31 | 0 | 1 | 0 | €74.50 | €83.92 | 12.645% |
EyePoint Pharmaceuticals Inc. | 22 | 1 | 1 | 0 | €8.38 | €27.83 | 232.112% |
Sutro Biopharma Inc | 21 | 0 | 0 | 0 | €3.52 | €11.04 | 213.705% |
G1 Therapeutics | 21 | 1 | 0 | 0 | €3.64 | €10.54 | 189.813% |
Natural Alternat. | 21 | 1 | 3 | 0 | €5.05 | - | - |
TG Therapeutics Inc. | 21 | 2 | 0 | 0 | €18.07 | €28.06 | 55.310% |
Akero Therapeutics Inc | 18 | 0 | 0 | 0 | €26.11 | €38.62 | 47.925% |
Krystal Biotech | 17 | 0 | 0 | 0 | €196.65 | €186.59 | -5.116% |
Geron Corp. | 17 | 0 | 1 | 0 | €4.29 | €5.56 | 29.627% |
Esperion Therapeutis.Inc. | 17 | 1 | 3 | 0 | €2.23 | €8.55 | 282.691% |
Rhythm Pharmaceuticals | 16 | 0 | 1 | 0 | €45.60 | €46.37 | 1.689% |
Intellia Therapeutics Inc | 17 | 1 | 0 | 0 | €24.40 | €60.53 | 148.092% |
Corcept Therapeutics Inc. | 15 | 0 | 1 | 0 | €32.80 | €36.87 | 12.402% |
Rigel Pharmaceutical Inc. | 14 | 0 | 1 | 0 | €0.74 | €13.82 | 1767.203% |
Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | €16.20 | €24.44 | 50.882% |
Verastem Inc. | 12 | 0 | 2 | 0 | €2.72 | €17.56 | 545.441% |
MacroGenics Inc. | 12 | 0 | 0 | 0 | €5.10 | €12.42 | 143.622% |
Twist Bioscience Corp | 11 | 0 | 2 | 0 | €53.46 | €53.41 | -0.102% |
Prothena Corp. plc | 11 | 0 | 0 | 0 | €22.60 | €79.47 | 251.619% |
Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €2.80 | €4.63 | 64.971% |
Evolus Inc | 10 | 0 | 0 | 0 | €11.00 | €20.46 | 86.020% |
Chromadex Corp | 10 | 1 | 0 | 0 | €2.94 | €5.55 | 88.898% |
Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | €1.38 | €20.55 | 1388.986% |